Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
bc cancer pemetrexed | 0.51 | 0.9 | 6960 | 92 | 20 |
bc | 1.04 | 0.3 | 4069 | 44 | 2 |
cancer | 0.62 | 0.7 | 6294 | 12 | 6 |
pemetrexed | 1.69 | 0.4 | 7705 | 75 | 10 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
bc cancer pemetrexed | 0.17 | 0.9 | 3025 | 24 |
pemetrexed carboplatin bc cancer | 1.53 | 0.3 | 7544 | 13 |
pemetrexed carboplatin lung cancer | 0.15 | 0.5 | 2757 | 84 |
carboplatin pemetrexed radiation lung cancer | 1.59 | 0.6 | 2807 | 64 |
carboplatin and pemetrexed for lung cancer | 0.29 | 0.9 | 7393 | 45 |
carboplatin and pemetrexed chemotherapy | 1.89 | 0.2 | 3316 | 82 |
carboplatin pemetrexed concurrent radiation | 0.37 | 0.8 | 4648 | 60 |
carboplatin and pemetrexed macmillan | 0.76 | 0.9 | 2952 | 63 |
pemetrexed and carboplatin protocol | 0.54 | 0.7 | 6090 | 16 |
carboplatin and pemetrexed success | 1.22 | 1 | 2047 | 70 |
carboplatin pemetrexed pembrolizumab nsclc | 0.97 | 0.2 | 2821 | 67 |
carboplatin/pemetrexed | 0.18 | 0.2 | 4428 | 80 |
pemetrexed and carboplatin survival rate | 1.82 | 0.6 | 4893 | 98 |
carboplatin + pemetrexed + pembrolizumab | 1.22 | 0.4 | 8502 | 66 |
carboplatin pemetrexed pembrolizumab cco | 1.22 | 0.6 | 4920 | 40 |
carboplatin and pemetrexed mesothelioma | 1.93 | 0.3 | 9769 | 79 |